NCT01960491View on ClinicalTrials.gov

FIH Study With CBSO

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

June 30, 2018

Conditions
Atrial Septal Defect (ASD)Patent Foramen Ovale (PFO)
Interventions
DEVICE

Device Closure of Atrial Septal Defect

"Device Closure of Atrial Septal Defect by Carag Bioresorbable Septal Occluder"

Trial Locations (1)

Unknown

CardioVaskuläres Centrum, Frankfurt

All Listed Sponsors
lead

Carag AG

INDUSTRY

NCT01960491 - FIH Study With CBSO | Biotech Hunter | Biotech Hunter